# ArriVent BioPharma, Inc.: Form 8-K, filed Apr 28, 2025

- Company: [ArriVent BioPharma, Inc.](/companies/avbp.md) (CIK 1868279)
- Form: 8-K
- Filed: 2025-04-28
- Accepted by EDGAR: Apr 28, 2025, 08:15 ET
- Period: 2025-04-23
- Accession: 0001104659-25-039799
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1868279/000110465925039799/tm2513158d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1868279/000110465925039799/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1868279/000110465925039799/tm2513158d1_8k.htm

Filed Apr 28, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-039799. Last ingested by Listed: Nov 5, 2026, 13:51 ET. No prices; not investment advice.